Charles Schwab’s Oragenics OGEN Stock Holding History

Charles Schwab’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-56	Closed	-$10.6K	–	3577
2022 Q4	$10.6K	Hold	56	–	–	﹤0.01%	3529
2022 Q3	$23K	Hold	56	–	–	﹤0.01%	3469
2022 Q2	$35K	Buy	+56	New	+$32.3K	﹤0.01%	3447
2021 Q2	–	Sell	-24	Closed	-$39K	–	3502
2021 Q1	$39K	Buy	+24	New	+$43.6K	﹤0.01%	3465

Other funds holding OGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Charles Schwab's OGEN Position: Q1 2023 in Review

Charles Schwab sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 56 shares — an estimated $10.6K sold.

Charles Schwab first reported a position in OGEN in Q1 2021 and held it in 4 quarters. The position peaked at $39K in Q1 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.

Charles Schwab reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
Charles Schwab sold 56 Oragenics shares in Q1 2023, an estimated $10.6K.
Charles Schwab first reported a position in Oragenics in Q1 2021 and held it in 4 quarters.
Charles Schwab's Oragenics position peaked at $39K in Q1 2021.
10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.